In VivoEvolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniaeIs Associated with Low-Dosage Colistin Treatment

MLA

Cannatelli, Antonio, et al. “In VivoEvolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella PneumoniaeIs Associated with Low-Dosage Colistin Treatment.” Antimicrobial Agents and Chemotherapy, vol. 58, no. 8, June 2014, pp. 4399–403. EBSCOhost, https://doi.org/10.1128/AAC.02555-14.

APA

Cannatelli, A., Di Pilato, V., Giani, T., Arena, F., Ambretti, S., Gaibani, P., D’Andrea, M. M., & Rossolini, G. M. (2014). In VivoEvolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniaeIs Associated with Low-Dosage Colistin Treatment. Antimicrobial Agents and Chemotherapy, 58(8), 4399–4403. https://doi.org/10.1128/AAC.02555-14

Chicago

Cannatelli, Antonio, Vincenzo Di Pilato, Tommaso Giani, Fabio Arena, Simone Ambretti, Paolo Gaibani, Marco Maria D’Andrea, and Gian Maria Rossolini. 2014. “In VivoEvolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella PneumoniaeIs Associated with Low-Dosage Colistin Treatment.” Antimicrobial Agents and Chemotherapy 58 (8): 4399–4403. doi:10.1128/AAC.02555-14.